Related Experiment Video
Updated: Mar 22, 2026

Mouse Kidney Transplantation: Models of Allograft Rejection
Published on: October 11, 2014
Providing Better-Matched Donors for HLA Mismatched Compatible Pairs Through Kidney Paired Donation
Paolo Ferrari1, Linda Cantwell, Joseph Ta
11 Department of Nephrology and Transplantation, Prince of Wales Hospital, Sydney, NSW, Australia. 2 Clinical School, University of New South Wales, Sydney, Australia. 3 Victorian Transplantation and Immunogenetics Service, Australian Red Cross Blood Service, Melbourne, Victoria, Australia. 4 Department of Clinical Immunology, Fiona Stanley Hospital, Mudroch, WA, Australia. 5 School of Pathology and Laboratory Medicine, University of Western Australia, Perth, Australia.
Insights
Compatible pairs (CP) in kidney paired donation (KPD) can improve HLA matching for recipients with high mismatches. This strategy also enhances donation rates for incompatible pairs (ICP) without compromising their outcomes.
Area of Science:
- Nephrology
- Immunology
- Transplantation Science
Background:
- Kidney paired donation (KPD) programs traditionally serve incompatible pairs (ICP).
- Compatible pairs (CP) with high HLA mismatches may benefit from KPD if better matches are prioritized.
- Allocation metrics are needed to integrate CPs into KPD without disadvantaging ICPs.
Purpose of the Study:
- To evaluate the impact of compatible pair participation on HLA matching for both compatible and incompatible recipients within KPD simulations.
- To define allocation strategies that benefit CP recipients while ensuring no negative consequences for ICPs.
Main Methods:
- Simulations using the Australian KPD matching algorithm with 46 ICPs and 11 CPs.
- CPs were added individually or collectively, with and without exclusion of unacceptable antigens (70-80% virtual calculated panel-reactive antibody).
Main Results:
- CP recipients achieved significantly lower eplet mismatch (EpMM) compared to their own donors (57 ± 15 vs. 78 ± 19).
- Significant EpMM reduction was observed for CP recipients with an initial EpMM > 65.
- Including CPs increased ICP matching rates by up to 50%.
Conclusions:
- CP participation in KPD can improve HLA matching for CP recipients with high EpMM.
- KPD allocation strategies incorporating CPs enhance match rates for ICPs.
- Virtual crossmatch-based allocation benefits CP recipients and increases overall KPD efficiency.
Background:
Participation of compatible pairs (CP) in kidney paired donation (KPD) could be attractive to CPs who have a high degree of HLA mismatch, if the CP recipient will gain a better HLA match. Because KPD programs were not designed to help CP, it is important to define allocation metrics that enable CP to receive a better-matched kidney, without disadvantage to incompatible pairs (ICP).
Methods:
Simulations using 46 ICPs and 11 fully HLA-mismatched CPs were undertaken using the Australian KPD matching algorithm. Allocations were preformed adding 1 CP at a time or all 11 CPs at once, and with and without exclusion of unacceptable antigens selected to give a virtual calculated panel-reactive antibody ranging 70% to 80% to improve HLA matching in CP recipients.
Results:
On average, most CP recipients could be matched and had a lower eplet mismatch (EpMM) with the matched donor (57 ± 15) than with their own donor (78 ± 19, P < 0.02). However, only recipients who had an EpMM to own donor greater than 65 achieved a significant reduction in the EpMM with the matched donor. The gain in EpMM was larger when CPs were listed with unacceptable antigens. Furthermore, inclusion of 1 CP at a time increased matching in ICP by up to 33%, and inclusion of all 11 CPs at once increased ICP matching by 50%.
Conclusions:
Compatible pair participation in KPD can increase match rates in ICP and can provide a better immunological profile in CP recipients who have a high EpMM to their own donor when using allocation based on virtual crossmatch.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

